Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ECON Investor Relations was a boutique investor relations and strategic communications firm that specialized exclusively in the life sciences and healthcare sectors. Founded in 2005 and headquartered in New York, the firm provided high-level advisory services to both public and private companies, focusing on capital markets strategy, IPO preparation, and corporate messaging. The firm was recognized for its ability to translate complex clinical and scientific milestones into compelling investment narratives for the financial community. In April 2019, ECON Investor Relations was acquired by ICR, a leading global strategic communications and advisory firm. Following the acquisition, the ECON team was integrated into ICR Westwicke, the healthcare-focused division of ICR, to expand its presence in the New York market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ECON Investor Relations.